Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance
News Release
Severity, cost of comp claims on the rise
The workers' compensation sector remains a relatively stable and profitable segment of the commercial insurance industry, but some claims are getti
Workers' Comp
Article
Unlocking Value Across Market Segments Using a Holistic View
One of the biggest highlights of 2021 for the Mitchell, Genex and Coventry family of businesses was uniting under one unified brand – Enlyte.
SBWC
Conference
Georgia State Board of Workers' Compensation Annual Educational Conference
Risk & Insurance
News Release
How Miami-Dade Public Schools Helped Their Police Officers Fight COVID
Getting public school police officers the care they needed meant taking on the risk of visiting emergency rooms during the pandemic.
PC360
News Release
Workers' Comp Sector Has Embraced Electronic Payments
Workers' Comp
White Paper
A Personalized Approach to High-MED Opioid Management
Successful opioid management includes a tailored strategy that takes into account: Each injured worker’s current medication regime